Regadenoson 00409-1401-01

Package NDC

00409-1401-01

Manufacturer: Hospira, Inc.
Dosage Form: Injection, Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: March 1, 2023
Listing Expires: December 31, 2026
Application: ANDA214349

Need to source Regadenoson? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Regadenoson Anhydrous	.08 mg/mL

Drug Class

Pharmacologic Cardiac Stress Test Agent [EPC]Adenosine Receptor Agonists [MoA]Pharmacologic Cardiac Stress Test Agent [EPC]

Selected Package

00409-1401-01Selected

10 CARTON in 1 PACKAGE (0409-1401-01) / 1 SYRINGE, PLASTIC in 1 CARTON / 5 mL in 1 SYRINGE, PLASTIC (0409-1401-05)